Brief: Double Bond Pharmaceutical Says Received Eurasian Patent For Belogal Platform
23/10/2019 20:09
Oct 23 (Reuters) - Double Bond Pharmaceuticals International
AB :
* DOUBLE BOND PHARMACEUTICAL RECEIVES EURASIAN PATENT FOR
THE
BELOGAL® PLATFORM
Source text for Eikon: ID:nWkr2nCylR
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University